INSIGHTS ON QUALITY CONTROL
-
Contamination Control Of Particulate And Shuttle Blow-Fill-Seal Compliance
Does shuttle blow-fill-seal truly meet Annex 1’s stricter contamination standards? New particle burden data challenges industry assumptions and reveals what manufacturers need to know.
-
Understanding cGMPs For Phase 1 Investigational Drugs
Learn how a structured, risk-based approach to early-phase manufacturing can help streamline processes, reduce costs, and accelerate the path to first-in-human trials while meeting FDA cGMP guidelines.
-
Practical Considerations For Aseptic Gowning In Contamination Control Strategies
Master the complexities of aseptic gowning and Annex 1 compliance. Explore risk-based strategies to mitigate human-source contamination and strengthen your facility's sterility assurance.
-
Science With Purpose: Advancing Sustainability In Biopharma Testing
Learn how biopharma labs are cutting animal use, energy, and paper waste while maintaining GMP compliance — with specific data on 85% labor reductions and 1 ton of CO2e saved annually.
-
Innovative Technology For Developing, Scaling Peptide-Based Therapeutics11/18/2024
Watch as experts walk through several technologies and case studies, focusing on liquid-phase peptide synthesis, crystallization, method development for impurity analysis, and more.
-
Physical Contamination Detection3/23/2026
Learn how physical contaminants enter production lines and how detection systems like metal detection and X-ray inspection help prevent defects and recalls to strengthen quality control.
-
Global Regulatory Compliance For Aseptic Barrier Systems6/24/2026
Reconcile differing regulatory philosophies in sterile manufacturing. Learn to use prescriptive baselines and scientific data to achieve global compliance.
-
Pharmaceutical Requirements For Portable Monitoring In Cleanrooms3/5/2026
Maintain rigorous pharmaceutical cleanroom standards through strategic environmental monitoring. Explore essential guidelines for particle detection and effective data analysis to ensure compliance.
-
Navigating The Analytical Complexity Of Oligonucleotide Therapeutics9/13/2024
From identity and purity testing using chromatography and electrophoresis to PCR and microbial studies, explore advanced analytical solutions tailored for siRNA, miRNA, pDNA, and mRNA products.
QUALITY CONTROL SOLUTIONS
-
Non-destructive package testing of multi-cavity blisters – completely tool-less for different blister formats.
-
See more with the latest in X-ray technology: detect metals and foreign materials, perform quality checks, reduce process time, and more. Explore the specifications and details here.
-
Optimize your line efficiency with accumulation between the upstream and downstream machines. Our accumulators let you decouple two machines, meaning you can run different equipment at varying speeds while still maintaining balance in the event of upstream or downstream stoppages.
-
TSI’s cleanroom facility environmental monitoring products with built-in redundancy provide the confidence you need to reliably monitor critical processes and demonstrate compliance.
-
Bringing complex therapies to market requires seamless integration across development, manufacturing, and regulatory strategy to reduce risk, speed timelines, and ensure quality.